5-132660197-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_002188.3(IL13):c.356G>A(p.Arg119Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00042 in 1,614,140 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0018 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00028 ( 0 hom. )
Consequence
IL13
NM_002188.3 missense
NM_002188.3 missense
Scores
1
16
Clinical Significance
Conservation
PhyloP100: -0.255
Genes affected
IL13 (HGNC:5973): (interleukin 13) This gene encodes an immunoregulatory cytokine produced primarily by activated Th2 cells. This cytokine is involved in several stages of B-cell maturation and differentiation. It up-regulates CD23 and MHC class II expression, and promotes IgE isotype switching of B cells. This cytokine down-regulates macrophage activity, thereby inhibits the production of pro-inflammatory cytokines and chemokines. This cytokine is found to be critical to the pathogenesis of allergen-induced asthma but operates through mechanisms independent of IgE and eosinophils. This gene, IL3, IL5, IL4, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL4. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0073035657).
BP6
Variant 5-132660197-G-A is Benign according to our data. Variant chr5-132660197-G-A is described in ClinVar as [Benign]. Clinvar id is 3045158.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL13 | NM_002188.3 | c.356G>A | p.Arg119Gln | missense_variant | 4/4 | ENST00000304506.7 | NP_002179.2 | |
IL13 | NM_001354991.2 | c.161G>A | p.Arg54Gln | missense_variant | 5/5 | NP_001341920.1 | ||
IL13 | NM_001354992.2 | c.161G>A | p.Arg54Gln | missense_variant | 6/6 | NP_001341921.1 | ||
IL13 | NM_001354993.2 | c.161G>A | p.Arg54Gln | missense_variant | 5/5 | NP_001341922.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL13 | ENST00000304506.7 | c.356G>A | p.Arg119Gln | missense_variant | 4/4 | 1 | NM_002188.3 | ENSP00000304915.3 |
Frequencies
GnomAD3 genomes AF: 0.00179 AC: 273AN: 152180Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
273
AN:
152180
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000525 AC: 132AN: 251396Hom.: 0 AF XY: 0.000419 AC XY: 57AN XY: 135894
GnomAD3 exomes
AF:
AC:
132
AN:
251396
Hom.:
AF XY:
AC XY:
57
AN XY:
135894
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000276 AC: 403AN: 1461842Hom.: 0 Cov.: 37 AF XY: 0.000260 AC XY: 189AN XY: 727222
GnomAD4 exome
AF:
AC:
403
AN:
1461842
Hom.:
Cov.:
37
AF XY:
AC XY:
189
AN XY:
727222
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00181 AC: 275AN: 152298Hom.: 2 Cov.: 33 AF XY: 0.00185 AC XY: 138AN XY: 74482
GnomAD4 genome
AF:
AC:
275
AN:
152298
Hom.:
Cov.:
33
AF XY:
AC XY:
138
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
26
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
87
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
IL13-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 07, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Benign
.;T
Sift4G
Benign
T;T
Vest4
MVP
MPC
0.18
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at